论文部分内容阅读
我院自1995年7月～1996年8月应用兰索拉唑治疗十二指肠球部溃疡,并以法莫替丁为对照,对比观察其近期疗效。现报道如下。 1 临床资料 经胃镜检查确诊为十二指肠球部活动性溃疡120例,随机分为兰索拉唑组60例,法莫替丁组60例。两组在年龄、性别、职业、疗程、吸烟史、症状、溃疡面积方面无明显差异,具有可比性。 2 方法 2.1 兰索拉唑组:兰索拉唑(天津武田药品株式会社生产)30mg,每天早晨空腹1次口服,疗程6周。法莫替丁组:法莫替丁40mg,每天分2次口服,疗程6周。治疗期间均不加用其它抗溃疡药物。
In our hospital from July 1995 to August 1996 application of lansoprazole treatment of duodenal ulcer, and famotidine as a control, the comparative observation of its immediate effect. Report as follows now. 1 clinical data confirmed by gastroscopy duodenal ulcer in 120 cases were randomly divided into lansoprazole group 60 cases, famotidine group 60 cases. The two groups in age, gender, occupation, treatment, smoking history, symptoms, ulcer area no significant difference, comparable. 2 Methods 2.1 Lansoprazole group: Lansoprazole (Tianjin Takeda Pharmaceutical Co., Ltd.) 30mg, 1 fasting once daily oral, treatment for 6 weeks. Famotidine group: famotidine 40mg, 2 times daily oral, treatment for 6 weeks. During the treatment are not added with other anti-ulcer drugs.